Drug intelligence / Profile preview

liriopis tuber extract

Development stage
Preclinical
Administration
Oral
01

Overview

Liriopis tuber extract is a traditional herbal medicine derived from the tuber of *Liriope platyphylla* Wang et Tang, a member of the Liliaceae family. Historically used in East Asian medicine for treating respiratory ailments such as cough, sputum production, and asthma, the extract has been the subject of preclinical investigation for its immunomodulatory and anti-inflammatory properties. Its mechanism of action involves the suppression of proinflammatory mediators, including nitric oxide and cytokines such as IL-6, IL-10, and IL-12p40, as well as the inhibition of transcription factors like NF-κB and CREB. In murine models of asthma, the extract has demonstrated the ability to reduce airway hyperresponsiveness and eosinophilic inflammation by modulating the Th1/Th2 cytokine balance, specifically decreasing levels of IL-4, IL-5, IL-13, and IgE.

Other names
Liriope platyphylla extractLiriope platyphylla tuber extract
02

Targets

IL-6 (Interleukin 6)IL-4 (Interleukin 4)NF-κBIL-13 (Interleukin-13)IL-5 (Interleukin 5)

Beyond the preview

Go deeper on liriopis tuber extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on liriopis tuber extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call